Chemotherapy of Disseminated Merkel-Cell Carcinoma

Abstract
Six patients developed metastatic merkel-cell carcinoma and were treated with a combination chemotherapy frequently used for small-cell lung cancer. Five of six patients had a complete response for a median of 3.5 months. Overall survival from initiation of chemotherapy was a median of 6.5 months. Two patients died from major complications of therapy.

This publication has 0 references indexed in Scilit: